BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Intersect ENT Announces Appointment of Thomas A. West as CEO

  Intersect ENT®, Inc. (Nasdaq:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of Thomas (“Tom”) A. West as President and Chief Executive Officer, effective July 22, 2019.

  June 27, 2019

   · 

  5 min read
• Business

  McKesson Corporation to Announce First Quarter Fiscal 2020 Results on July 31, 2019

  McKesson Corporation (NYSE:MCK) announced today that its first quarter fiscal 2020 financial results will be released on Wednesday, July 31, 2019 following the close of market.

  June 27, 2019

   · 

  1 min read
• Deals

  McKesson Issues Statement on Change Healthcare IPO

  McKesson Corporation (NYSE:MCK) offers the below statement on today’s Change Healthcare initial public offering:

  June 27, 2019

   · 

  2 min read
• Business

  Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019

  Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the second quarter 2019 after the close of market on Tuesday, July 30, 2019.

  June 27, 2019

   · 

  1 min read
• Business

  Pfizer Declares Third-Quarter 2019 Dividend

  The Board of Directors of Pfizer Inc. today declared a 36-cent third-quarter 2019 dividend on the company’s common stock, payable September 3, 2019, to holders of the Common Stock of record at the close of business on August 2, 2019.

  June 27, 2019

   · 

  1 min read
• Business

  Scott Gottlieb Elected to Pfizer’s Board of Directors

  Pfizer Inc. (NYSE:PFE) today announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board.

  June 27, 2019

   · 

  2 min read
• INVESTORS SUPPORT PHAGE THERAPY: NOVEL APPROACH TO SOLVE THE ANTIBIOTICS CRISIS RECEIVES FURTHER MILLIONS

  Austrian biotech company PhagoMed Biopharma GmbH successfully completed another financing round. PhagoMed, located at the Vienna Biocenter, is focused on developing virus-(phage-) based therapies against drug-resistant and chronic bacterial infections.

  June 27, 2019

   · 

  3 min read